TAIxin, Taiwan — It’s hard to imagine a better time for Taiwan’s chemical industry than the time it’s currently experiencing.
As the number of new chemical plants expands and as the cost of making drugs, medicines, and other products continues to drop, TAI is in a unique position to make a comeback.
But there’s one problem.
Taiwan’s chemical plants are being shut down.
While it’s been more than a decade since the first plants opened in the city, Taiwan’s pharmaceutical industry is in its infancy, and most of its industry is being shuttered.
And while many of the plants have seen strong growth in recent years, the lack of capital investment and technological innovations have left Taiwan’s companies with few prospects.
As Taiwan struggles to make progress, its chemical industry is experiencing a crisis.
With no new factories to be built, Taiwan needs new sources of financing.
The country has one of the highest debt levels in the world, and that’s only getting worse.
And when Taiwan’s debt levels become too high, the country’s companies are forced to cut costs and shift production to China.
That’s the situation that the Taiwan Chemical Industry Council (TCIC) has been trying to fix.
Its first priority is to increase its own capacity and diversify its supply chains.
It recently launched a crowdfunding campaign on Indiegogo to raise $500 million to build a new chemical plant.
If successful, the goal would allow Taiwan to compete with China’s giant, state-owned ChemChina, and possibly with other big-name manufacturers like Pfizer, Johnson & Johnson, and Eli Lilly.
The TAIwan Chemical Industry has seen some success in recent times, however.
The first plant opened in 2012, and since then, it’s become a big part of Taiwan’s economy.
Its production of a number of pharmaceuticals has grown over the past decade and the city is now home to some of the world’s largest chemical plants.
The TAIs first plant in Taitung was completed in 2014, and it now produces about 5 percent of Taiwan s pharmaceutical products.
The second plant opened up in 2015, and by the time the third plant opened last year, it produced 20 percent of its drugs.
And the fourth plant opened this year, and its production is expected to grow to 20 percent.
The government plans to double the capacity of its existing plants over the next three years.
But even with the new plants, Taiwan will still be dependent on China to produce its drugs and medicines.
With China facing a crisis of its own, it would be extremely difficult for the country to compete on the world stage.
China’s economy has grown at a rate of nearly 40 percent annually over the last decade.
In the next two decades, the pace of growth will likely accelerate to 50 percent.
That means Taiwan’s export and domestic industries are going to be forced to focus on diversifying their supply chains to avoid competition with China.
To make things worse, the TACIC also needs a major boost in capital investment.
The current investment rate of about 6.8 percent is well below the average for major Asian economies, and there are few signs of any further capital inflows from the countrys private sector.
That’s why the TCAI, the state-run chemical company, has been pressing its government to create a fund to help its companies diversify.
Its initial fund of about $30 million is slated to increase to about $100 million over the coming years.
The biggest obstacle to that funding is that most Taiwanese companies don’t have the capital to spend on capital investments.
The result is that TCAIC’s funding is being used to pay for equipment and machinery that would be more likely to be sold overseas.
As a result, the government is running out of cash to fund its projects.
Taiwan is also dependent on foreign investors to pay the bills.
According to a report from the Taiwan Chamber of Commerce, foreign companies are spending about $50 billion a year on the country, and they are largely reluctant to invest.
With a budget deficit of about 10 percent, the situation could get even worse before it gets better.
That puts Taiwan in a precarious situation.
If its government continues to rely on foreign capital for funding, Taiwan could find itself in a downward spiral that will likely leave it unable to repay its debts.
That could have a knock-on effect on the broader economy.
Taiwan faces the threat of deflation in the coming decades.
But the government has no plans to let that happen.
While inflation has risen in recent months, it is still below the target rate of 1.8%.
In the meantime, Taiwan s government is preparing to spend tens of billions of dollars to expand its infrastructure and to build new plants to meet the rising demand for medicines and drugs.
The problem is that many of those